Talis Biomedical (NASDAQ:TLIS) Shares Up 77.5% – Still a Buy?
North American Morning Briefing : Global Ad Shares -2-
Why Is Talis Biomedical (TLIS) Stock Down 52% Today?
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
7 Small-Cap Stocks to Sell in August Before They Crash and Burn
Talis Biomedical Corporation (TLIS) Q2 2023 Earnings Call Transcript
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement
Talis Biomedical Corporation (TLIS) Q1 2023 Earnings Call Transcript
Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023
Press release Biocartis Group NV: Biocartis appoints Roger Moody as new CEO
Talis Biomedical Corporation (TLIS) CEO Rob Kelly on Q2 2022 Results - Earnings Call Transcript
Talis Biomedical Corporation(TLIS) CEO Rob Kelly on Q12022 Results - Earnings Call Transcript
Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022
Talis Biomedical stock bounces off record low after largest shareholder pulls share-sale plans
Talis Biomedical Corporation (TLIS) CEO Rob Kelly on Q4 2021 Results - Earnings Call Transcript
Talis Biomedical Corporation (TLIS) CEO Kim Popovits on Q3 2021 Results - Earnings Call Transcript
Talis Biomedical (TLIS) Stock: Why The Price Surged Today
Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis on Behalf of Talis Stockholders and Encourages Investors to Contact the Firm
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
The Law Offices of Frank R. Cruz Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
The Law Offices of Frank R. Cruz Announces Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
Talis Biomedical Announces CEO Transition
Talis Biomedical's (TLIS) CEO Brian Coe on Q2 2021 Results - Earnings Call Transcript
Talis Biomedical Corporation (TLIS) CEO Brian Coe on Q1 2021 Results - Earnings Call Transcript
Talis Biomedical Announces First Quarter 2021 Financial Results and Business Progress
4 Stocks With High Insider Cluster Buys During February and March
The Past Week's Notable Insider Buys: More Biotech IPOs, Bumble, Fiserv And More